Wells Fargo’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.9M | Sell |
41,278
-6,778
| -14% | -$3.13M | ﹤0.01% | 1568 |
|
|
2026
Q1 | $23.1M | Buy |
48,056
+3,302
| +7% | +$1.69M | ﹤0.01% | 1418 |
|
|
2025
Q4 | $25.1M | Buy |
44,754
+633
| +1% | +$359K | ﹤0.01% | 1339 |
|
|
2025
Q3 | $22.7M | Sell |
44,121
-8,830
| -17% | -$3.86M | ﹤0.01% | 1396 |
|
|
2025
Q2 | $16.6M | Buy |
52,951
+18,175
| +52% | +$5.46M | ﹤0.01% | 1539 |
|
|
2025
Q1 | $10.6M | Buy |
34,776
+2,353
| +7% | +$791K | ﹤0.01% | 1815 |
|
|
2024
Q4 | $10.8M | Sell |
32,423
-739
| -2% | -$251K | ﹤0.01% | 1816 |
|
|
2024
Q3 | $11.1M | Sell |
33,162
-12,994
| -28% | -$4.94M | ﹤0.01% | 1739 |
|
|
2024
Q2 | $19M | Buy |
46,156
+4,958
| +12% | +$1.96M | ﹤0.01% | 1274 |
|
|
2024
Q1 | $16.7M | Sell |
41,198
-6,960
| -14% | -$2.45M | ﹤0.01% | 1350 |
|
|
2023
Q4 | $14.8M | Sell |
48,158
-448
| -0.9% | -$121K | ﹤0.01% | 1393 |
|
|
2023
Q3 | $11.8M | Sell |
48,606
-39,802
| -45% | -$10.2M | ﹤0.01% | 1449 |
|
|
2023
Q2 | $21.2M | Sell |
88,408
-23,033
| -21% | -$4.78M | 0.01% | 1086 |
|
|
2023
Q1 | $21M | Sell |
111,441
-15,771
| -12% | -$3.26M | 0.01% | 1109 |
|
|
2022
Q4 | $27M | Sell |
127,212
-27,557
| -18% | -$5.51M | 0.01% | 944 |
|
|
2022
Q3 | $24.3M | Sell |
154,769
-8,616
| -5% | -$1.37M | 0.01% | 974 |
|
|
2022
Q2 | $24.5M | Buy |
163,385
+73,633
| +82% | +$10.7M | 0.01% | 1029 |
|
|
2022
Q1 | $14.7M | Sell |
89,752
-4,933
| -5% | -$813K | ﹤0.01% | 1540 |
|
|
2021
Q4 | $20.6M | Sell |
94,685
-20,858
| -18% | -$4.37M | 0.01% | 1319 |
|
|
2021
Q3 | $21.9M | Sell |
115,543
-2,809
| -2% | -$512K | ﹤0.01% | 1588 |
|
|
2021
Q2 | $20.9M | Sell |
118,352
-22,146
| -16% | -$3.82M | ﹤0.01% | 1649 |
|
|
2021
Q1 | $23M | Sell |
140,498
-23,165
| -14% | -$3.54M | 0.01% | 1564 |
|
|
2020
Q4 | $22.8M | Buy |
163,663
+24,633
| +18% | +$3.1M | 0.01% | 1467 |
|
|
2020
Q3 | $15.5M | Sell |
139,030
-1,992
| -1% | -$230K | ﹤0.01% | 1580 |
|
|
2020
Q2 | $13.1M | Sell |
141,022
-2,553
| -2% | -$217K | ﹤0.01% | 1643 |
|
|
2020
Q1 | $10.5M | Buy |
143,575
+15,852
| +12% | +$1.38M | ﹤0.01% | 1637 |
|
|
2019
Q4 | $10.7M | Sell |
127,723
-6,795
| -5% | -$526K | ﹤0.01% | 1913 |
|
|
2019
Q3 | $11.3M | Buy |
134,518
+4,710
| +4% | +$356K | ﹤0.01% | 1857 |
|
|
2019
Q2 | $8.49M | Buy |
129,808
+29,285
| +29% | +$1.69M | ﹤0.01% | 2090 |
|
|
2019
Q1 | $5.93M | Sell |
100,523
-226,749
| -69% | -$13.5M | ﹤0.01% | 2394 |
|
|
2018
Q4 | $17.3M | Buy |
327,272
+245,981
| +303% | +$13.5M | 0.01% | 1461 |
|
|
2018
Q3 | $4.87M | Buy |
81,291
+59,409
| +271% | +$3.25M | ﹤0.01% | 2669 |
|
|
2018
Q2 | $941K | Buy |
21,882
+5,057
| +30% | +$204K | ﹤0.01% | 4036 |
|
|
2018
Q1 | $588K | Sell |
16,825
-2,878
| -15% | -$105K | ﹤0.01% | 4276 |
|
|
2017
Q4 | $714K | Buy |
19,703
+9,349
| +90% | +$328K | ﹤0.01% | 4136 |
|
|
2017
Q3 | $330K | Buy |
10,354
+3,104
| +43% | +$94.8K | ﹤0.01% | 4611 |
|
|
2017
Q2 | $210K | Sell |
7,250
-4,797
| -40% | -$135K | ﹤0.01% | 4752 |
|
|
2017
Q1 | $360K | Sell |
12,047
-20,971
| -64% | -$677K | ﹤0.01% | 4462 |
|
|
2016
Q4 | $1.19M | Sell |
33,018
-15,825
| -32% | -$527K | ﹤0.01% | 3563 |
|
|
2016
Q3 | $1.46M | Buy |
+48,843
| New | +$1.43M | ﹤0.01% | 3208 |
|
Other funds holding MEDP
WA
Wells Fargo's MEDP Position: Q2 2026 in Review
Wells Fargo reduced its Medpace (MEDP) stake by 14% in Q2 2026, selling an estimated $3.13M and leaving 41,278 shares worth $21.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1568.
Wells Fargo first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $27M in Q4 2022. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Wells Fargo held 41,278 shares of Medpace worth $21.9M as of Q2 2026.
- Wells Fargo sold 6,778 Medpace shares in Q2 2026, an estimated $3.13M.
- Medpace made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1568 holding.
- Wells Fargo first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- Wells Fargo's Medpace position peaked at $27M in Q4 2022.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.